PAREXEL - Rich Gleeson, VP, Discusses Asset Transfers at DIA 2016
Richard Gleeson, VP of Alliances discusses trends in asset transfers at DIA 2016. One key topic that we’re hearing from our customers this year is asset transfers, mergers and acquisitions and really how to preserve value in moving those trials from one entity to another. As a biopharmaceuticals services provider, we have both the clinical side of the business as well as the technology side of the business, so we’re able to fashion a solution that really allows them to get the most value out of that asset transfer, be it backfilling staff, be it providing technology, be it regulatory advice- all the things you really need to make those asset transfers worthwhile. One of the differentiators for PAREXEL Informatics is the fact that we have a whole platform of applications that we can offer to our customers doing the asset transfers, so even if they have 3rd party applications or legacy applications we can fill in the gaps and really build a solution that’s going to drive the most value for our customers.